Sarcoma
(Jan 1998)
A Phase II Study of Docetaxel in Chemotherapy-Naïve Patients With Recurrent or Metastatic Adult Soft Tissue Sarcoma
Vivien Bramwell,
Martin Blackstein,
Karl Belanger,
Shail Verma,
Sandra Beare,
Elizabeth Eisenhauer
Affiliations
Vivien Bramwell
London Regional Cancer Centre, Ontario, Canada
Martin Blackstein
Mt Sinai Hospital, Toronto, Canada
Karl Belanger
Hopital Notre-Dame, Montreal, Canada
Shail Verma
Ottawa Regional Cancer Centre, Ontario, Canada
Sandra Beare
National Cancer Institute of Canada Clinical Trials Group (NCIC-CTG), Ontario, Kingston, Canada
Elizabeth Eisenhauer
National Cancer Institute of Canada Clinical Trials Group (NCIC-CTG), Ontario, Kingston, Canada
DOI
https://doi.org/10.1080/13577149878136
Journal volume & issue
Vol. 2,
no. 1
pp.
29
– 33
Abstract
Read online
Purpose: To determine the efficacy and toxicity of docetaxel as first-line chemotherapy in adult patients with locally advanced and/or metastatic soft tissue sarcoma (STS).
WeChat QR code
Close